A detailed history of Buckhead Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Buckhead Capital Management LLC holds 4,879 shares of ABT stock, worth $574,014. This represents 0.18% of its overall portfolio holdings.

Number of Shares
4,879
Previous 5,204 6.25%
Holding current value
$574,014
Previous $591,000 14.38%
% of portfolio
0.18%
Previous 0.21%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$100.73 - $112.44 $32,737 - $36,543
-325 Reduced 6.25%
4,879 $506,000
Q1 2024

May 03, 2024

SELL
$109.52 - $120.96 $123,648 - $136,563
-1,129 Reduced 17.83%
5,204 $591,000
Q4 2023

Feb 05, 2024

BUY
$90.19 - $110.4 $2,705 - $3,312
30 Added 0.48%
6,333 $697,000
Q3 2023

Nov 09, 2023

SELL
$95.53 - $114.62 $37,829 - $45,389
-396 Reduced 5.91%
6,303 $610,000
Q2 2023

Aug 10, 2023

SELL
$100.78 - $112.29 $7,558 - $8,421
-75 Reduced 1.11%
6,699 $730,000
Q1 2023

May 11, 2023

SELL
$96.86 - $114.01 $89,595 - $105,459
-925 Reduced 12.01%
6,774 $685,000
Q4 2022

Feb 08, 2023

SELL
$95.06 - $111.52 $87,930 - $103,156
-925 Reduced 10.73%
7,699 $845,000
Q2 2022

Aug 05, 2022

SELL
$102.07 - $123.37 $8,675 - $10,486
-85 Reduced 0.98%
8,624 $937,000
Q4 2021

Feb 08, 2022

BUY
$115.53 - $141.46 $2,310 - $2,829
20 Added 0.23%
8,709 $1.23 Million
Q2 2021

Aug 06, 2021

SELL
$105.79 - $124.53 $17,984 - $21,170
-170 Reduced 1.92%
8,689 $1.01 Million
Q1 2021

Apr 27, 2021

BUY
$108.84 - $128.23 $16,326 - $19,234
150 Added 1.72%
8,859 $1.06 Million
Q4 2020

Feb 09, 2021

BUY
$105.0 - $114.42 $119,490 - $130,209
1,138 Added 15.03%
8,709 $954,000
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $66,897 - $81,241
730 Added 10.67%
7,571 $824,000
Q2 2020

Aug 03, 2020

BUY
$76.57 - $98.0 $523,815 - $670,418
6,841 New
6,841 $625,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Buckhead Capital Management LLC Portfolio

Follow Buckhead Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckhead Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Buckhead Capital Management LLC with notifications on news.